This chapter is the diagnostic and corrective layer that sits underneath every other module in this Path. Skip it and Phase 2 will underperform regardless of compliance.
What's actually happening underneath the GH stack
Three hormone systems gate whether GH and IGF-1 can actually do their job at the muscle cell:
Testosterone is the protein synthesis switch. Inside muscle tissue, testosterone simultaneously stimulates protein synthesis (the anabolic effect) and inhibits protein degradation (the anti-catabolic effect). Combined, these two actions account for the bulk of testosterone-driven muscle accrual — not a vague "more T = more gains" handwave, but two distinct and measurable mechanisms operating at the cellular level. When total and free testosterone are in the lower third of the reference range, the GH pulse you generated at 2 a.m. has nothing to drive against. You will produce IGF-1. You will not produce hypertrophy at the rate the IGF-1 reading predicts.
fT3 is the metabolic rate dial that controls anabolism's energy budget. Active thyroid hormone (T3) drives the mitochondrial rate at which amino acids get incorporated into new muscle protein. Only about 7% of circulating thyroid hormone is the active T3 form — the rest is inactive T4 that must be converted peripherally via the D1/D2 deiodinase pathways. When the body senses scarcity — chronic caloric deficit, overtraining, inadequate carbohydrate — it shunts T4 toward reverse T3 instead of active T3, blocking T3's effect at the receptor. The result: a normal-looking TSH, a normal-looking T4, and a body that is metabolically running on a fraction of its anabolic capacity. The practitioner corpus is explicit: testing TSH alone is insufficient. You need free T3, reverse T3, and ideally the ratio between them.
Cortisol is the demolition crew you do not want on the job site during a build phase. Cortisol mobilizes amino acids for energy by breaking down muscle tissue, decreases fat oxidation (paradoxically increasing fat storage), and suppresses immune function. Chronically elevated cortisol from overtraining or under-recovery directly antagonizes the testosterone and GH signaling that the rest of this Path is trying to amplify. The substrate is clear on the asymmetry: high-intensity-correlated bumps in testosterone and growth hormone are antagonistic to excess cortisol — but only if the cortisol axis is in working order. If you are training in a chronically elevated cortisol state, the antagonism collapses and the catabolic side wins.
The diagnostic threshold before you stack anything
Before Phase 2 of this Path, every one of these three needs to be on a label, not a hunch:
- Total testosterone, free testosterone, SHBG, LH, FSH — if free T is in the lower third, you are leaving 30-50% of the GH/IGF stack's effect on the table.
- TSH, free T4, free T3, reverse T3 — TSH alone is insufficient. Reverse T3 is the leading indicator that gets caught when only TSH is checked.
- Morning cortisol (8 a.m.), ideally a four-point salivary curve — a single morning draw catches the gross dysfunction; the curve catches the inverted/flattened patterns that block recovery.
If any of these are off, the supporting-axis correction comes before layering more growth stack on top.
The supporting-axis correction stack
| Compound | Dose | Route | Frequency | Evidence Tier | Notes |
|---|---|---|---|---|---|
| Kisspeptin-10 | 100-300 mcg | SubQ | 2x/day (pulsatile preferred) | Experimental | Upstream HPG axis stimulation — acts above GnRH. For men with suppressed LH/FSH and low natural T who want to restart endogenous production rather than enter TRT. |
| Kisspeptin-10 (TRT-adjunct dose) | 50-100 mcg | SubQ | Daily | Experimental | More physiologic alternative to HCG for maintaining HPG axis activity during TRT. Inject on TRT injection days. |
| Gonadorelin | [practitioner corpus thin on specific dose for recomp use — track and report] | SubQ | Pulsatile | Expert | Direct GnRH agonist. Used to drive LH/FSH when kisspeptin response is inadequate. |
| HCG | [practitioner corpus thin on dose detail in this substrate — track and report] | SubQ | 2-3x/week | Clinical | Standard TRT-adjunct for testicular function and downstream T support. |
| BPC-157 | 500 mcg | SubQ (abdomen) | 2x/day | Expert | Cortisol/inflammation buffer alongside training load. Continues from Phase 1. |
| Ipamorelin | Per Path Phase 1 stack | SubQ | Morning fasted + before bed | Expert | GH pulse architecture — only effective when the supporting axis above is corrected first. |
The kisspeptin pathway deserves the most attention here because the practitioner corpus describes a specific phenomenon: kisspeptin administration recreates natural LH pulse physiology — the same rhythm the brain would generate on its own, not the flat-line signal that exogenous testosterone produces. The substrate frames it as "you're not a widget importer anymore — you're a consultant who retrains the factory and the workers." For a recomp Path where the goal is muscle accrual without permanently exiting endogenous hormone production, this matters.
One important caveat the corpus surfaces: in men where the bottleneck is purely LH (not GnRH), HCG can be the more direct and better-studied lever, with kisspeptin offering less marginal benefit. The diagnostic labs above tell you which case you are in.
What you should feel
The substrate does not commit to specific week-by-week subjective milestones for the supporting-axis correction. The practitioner consensus is that lab response is the leading indicator and subjective response is the lagging indicator — expect labs to move 4-8 weeks before lifting performance, libido, recovery, and sleep architecture meaningfully shift. Track the markers, not the feelings, for the first month.
What's NOT happening yet
- You are not building muscle from the supporting-axis stack itself. Kisspeptin, gonadorelin, and HCG do not directly drive hypertrophy. They restore the hormonal substrate that lets the GH/IGF stack actually work.
- Reverse T3 will not drop overnight. If chronic caloric deficit or overtraining drove rT3 up, the correction is upstream — calories, carbohydrate, training volume — and the lab marker lags the behavioral fix by weeks.
- Cortisol will not "normalize" from a peptide alone. The cortisol correction is training-load, sleep, and lifestyle. Peptides buffer; they do not override a broken recovery context.
- TSH "in range" is not the all-clear. A normal TSH with elevated reverse T3 and depressed free T3 is the most common silent saboteur of this Path. Do not skip the full panel.
- Endogenous testosterone restoration takes 6-14 weeks of post-protocol labs to fully read. The corpus is explicit: pull total T, free T, LH, FSH at week 6 and week 12-14 to know whether the restart actually took.
Practitioner consensus describes these axes as the gates. Test them, correct them, then let the stack do its work.